SMi reports: Workshop Overview for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 15th September 2020 one day before the conference taking
SMi reports: Registration is now open for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 16th – 17th September 2020.
SMi are pleased to announce the launch of the Respiratory Drug Delivery conference as part of the newly branded Asthma and COPD series, which will be held in London on the 13th – 14
Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho